Pharmocann Global (XTAE:PMCN-M) 3-Year Revenue Growth Rate : -44.20% (As of Dec. 2023)

View and export this data going back to 2006. Start your Free Trial

What is Pharmocann Global 3-Year Revenue Growth Rate?

Pharmocann Global's Revenue per Share for the three months ended in Dec. 2023 was ₪0.00.

During the past 12 months, Pharmocann Global's average Revenue per Share Growth Rate was -71.80% per year. During the past 3 years, the average Revenue per Share Growth Rate was -44.20% per year. During the past 5 years, the average Revenue per Share Growth Rate was -21.40% per year. During the past 10 years, the average Revenue per Share Growth Rate was -28.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 12 years, the highest 3-Year average Revenue per Share Growth Rate of Pharmocann Global was 155.70% per year. The lowest was -81.80% per year. And the median was -11.00% per year.

Competitive Comparison of Pharmocann Global's 3-Year Revenue Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Pharmocann Global's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Pharmocann Global's 3-Year Revenue Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Pharmocann Global's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Pharmocann Global's 3-Year Revenue Growth Rate falls into.

Pharmocann Global 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

Pharmocann Global (XTAE:PMCN-M) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.

Pharmocann Global 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Pharmocann Global's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Pharmocann Global (XTAE:PMCN-M) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Pharmocann Global Ltd (XTAE:PMCN-M) » Definitions » 3-Year Revenue Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

Ramat Yishai, PO Box 305, Kiryat Tivon, ISR, 3601201

Website

https://www.pharmocann.co.il

Pharmocann Global Ltd is an Israel-based company engaged in producing medical-related cannabis products which include oil, ointments, tablets, inhalers, rectal and vaginal suppositories, and pre-rolled cigarettes of various types of THC/CBD strains.

Pharmocann Global (XTAE:PMCN-M) Headlines

No Headlines